REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector. read more
Ken Mills REGENXBIO CEO Rating
Ken Mills REGENXBIO CEO Rating
REGENXBIO's CEO, Ken Mills, has 10 employee ratings and a score of 72/100, placing them in the Top 40% of similar size companies on Comparably with 1-10 Employees and Top 35% of other companies in Washington, DC.
Where This Score Ranks REGENXBIO's CEO Rating
- TOP40%
In the Top 40% of 2052 Similar Sized Companies on Comparably
- TOP35%
In the Top 35% of 221 Nearby Companies in Washington, DC
- 2nd
2nd place versus 3 competitors rated on Comparably
73
Mar
76
Dec
78
Jan
79
Feb
71
Feb
B-72 / 100
Jan
REGENXBIO CEO Ken Mills Bio
Ken Mills serves as the CEO / President of REGENXBIO.
Not Enough Ratings To Show Who Ranks CEO Rating the Highest
Anonymously rate my experience at REGENXBIONot Enough Ratings To Show Who Ranks CEO Rating the Lowest
Anonymously rate my experience at REGENXBIOREGENXBIO CEO Ken Mills At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at REGENXBIO.
Based on 10 ratings, Ken Mills ranks right below Intellia Therapeutics' CEO, John Leonard.
Overall, the CEO score has remained stable over the last 90 days.
REGENXBIO CEO Ken Mills Rating Trendline
- REGENXBIO72
- Other Companies in Washington, DC
- Similar Size on Comparably
REGENXBIO's CEO Rating Rank Against Similar Sized Companies on Comparably
TOP
40%
REGENXBIO ranks in the Top 40% of other companies on Comparably with 1-10 Employees for CEO Rating Score.
REGENXBIO's CEO Rating Rank Against Other Companies Nearby
TOP
35%
REGENXBIO ranks in the Top 35% of other companies in Washington, DC for CEO Rating Score.
Anonymously Ask REGENXBIO Any Question
Are You an Employee at REGENXBIO?
Anonymously Rate Your Experience & Make Work BetterSee other culture dimensions at REGENXBIO
Related Articles
×